| |
NewswireToday - /newswire/ -
Dubai, UAE, United Arab Emirates, 02/16/2008 - IEMs (inborn errors of metabolisms) prevent babies from 'processing' food properly, leading to an accumulation of toxic chemicals in the blood, which are harmful for their normal development.
|
| |
The tests detect abnormal levels of these chemicals shortly after the baby is born.
One of the best reasons to have your infant screened is because many rare disorders that manifest in children often mimic more common diseases making diagnosis difficult and challenging. Children may fall morbidly ill before a proper diagnosis is obtained. Using the results from IEMs screening, physicians have an advantage of recognizing specific illnesses prior to the onset of symptoms, thereby paving the way for early intervention.
Dubai based Biotechnology Company Eastern Biotech & Life Sciences, is now offering state-of-the-art, supplemental screening for more than 50 rare and treatable metabolic disorders (i.e. Phenylketonuria, Galactosemia). The screening is performed on a small sample of blood obtained by pricking the baby's heel. The blood is allowed to dry on absorbent paper and sent to Eastern Biotech. Just a simple drop of blood taken at birth can help detect devastating metabolic disorders in infants.
"Metabolic disorders are not common, but they do occur, and are usually serious and often deadly," said Dr, Sanjida Ahmed, Director Research at Eastern Biotech. "The supplemental screening program allows us to identify these conditions soon after the birth and start the treatment before the babies suffer brain damage or other permanent disorders." The effect of genetic and congenital disorders in Arab countries is high.
"We are pleased to offer this screening program in the Middle East ," said Pankaj Sohaney, Manager of Eastern Biotech. The first time in Healthcare Industry Eastern Biotech is introducing Gift coupons for the test so that nearer & dearer of the new born can present this priceless gift which is required once in a life time. The newborn screening program "NBS" has two major benefits: first, it identifies the babies who need treatment as early as possible, and second, it provides peace of mind to the parents whose newborns are healthy."
About Eastern Biotech
Eastern Biotech & Life Sciences became one of the corporate client entities of DuBiotech in November 2005. Its vision is to promote the health of the people of the United Arab Emirates and the region through the introduction of biotechnological products and systems, and through research into the diseases relevant to this region, especially Genetic Disorders, Obesity, Diabetes and Heart diseases.
|
pankaj[.]easternbiotech.com 
